Placebo Cohort B

OTHER3 trials

Sponsors

Regenera Pharma Ltd, International Vaccine Institute, Genova Inc.

Conditions

Cholera Vaccination ReactionNonarteritic Anterior Ischemic Optic NeuropathyRespiratory

Phase 1

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

CompletedNCT05559983

International Vaccine InstituteCholera Vaccination Reaction

Start: 2022-12-05End: 2024-01-23Updated: 2025-03-25

Phase 2

Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

TerminatedNCT03547206

Regenera Pharma LtdNonarteritic Anterior Ischemic Optic Neuropathy

Start: 2018-07-10End: 2020-09-27Updated: 2020-10-12

Phase 3

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon + SOC vs. Placebo + SOC in Hospitalized Adult Patients with Moderate to Severe COVID-19

Active, not recruitingPACTR202107692340845

Genova Inc.Respiratory

Start: 2021-09-05Target: 914Updated: 2026-08-03